Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE)
Acta Neuropathologica · 15.05.2026 · 151 (1)
DOI: 10.1007/s00401-026-03027-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Neuropathologica, online erschienen am 15.05.2026. Verfasst von Ling Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, NC, USA. Hauptthemen laut MEDLINE: TDP-43 Proteinopathies, Limbic System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, North Carolina Biotechnology Center Translational Research Grant, NIH HHS.
Abstract (Originalsprache)
Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a neurodegenerative disease marked by TDP-43 proteinopathy, affecting approximately one-third of individuals aged 80 and above. LATE neuropathological change (LATE-NC) is characterized by the accumulation of phosphorylated TDP-43 preferentially in the limbic system, with potential extension to the neocortex and other brain regions. Notably, the anatomic pattern of LATE-NC differs from that seen in frontotemporal lobar degeneration with TDP-43-immunoreactive inclusions (FTLD-TDP). LATE-NC can occur in a “pure” form but more commonly exists alongside other dementia-related comorbidities, including both degenerative and vascular pathologies. When those “mixed” pathologies are factored in, LATE contributes significantly to cognitive decline in human populations. However, LATE currently lacks a molecular-specific diagnostic method for definitive diagnosis in living people. There are new consensus-based guidelines for predicting the presence of either pure LATE-NC or LATE-NC combined with Alzheimer’s disease neuropathologic change (ADNC). Aimed at developing more specific diagnostic methods, recent research efforts have been directed toward identifying unique features on neuroimaging and molecular signatures in biological fluids such as blood and cerebrospinal fluid to facilitate clinical diagnosis for LATE. This review discusses current progress in molecular understanding of LATE-NC, the search for biomarkers for LATE, and highlights key gaps that need to be addressed to advance early detection and improve patient management and clinical trial stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, NC, USA.
- Duke-UNC Alzheimer's Disease Research Center, Durham, NC, USA.
- Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, USA.
- Department of Pathology, University of Kentucky, Lexington, KY, USA.
- Sanders-Brown Center On Aging, University of Kentucky, Lexington, KY, USA.
- Duke-UNC Alzheimer's Disease Research Center, Durham, NC, USA. shihhsiu.wang@duke.edu.
Förderung
- NIA NIH HHS
- North Carolina Biotechnology Center Translational Research Grant
- NIH HHS
- NINDS NIH HHS
- Duke Clinical and Translational Science Institute
- National Institutes of Health
- Duke/UNC Alzheimer’s Disease Research Center REC Scholar award
- North Carolina Central University
Zitieren
APA
Wu, L., Akingbade, T., Nelson, P. T., Wang, S. J., & Xu, B. (2026). Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE). Acta Neuropathologica, 151(1). https://doi.org/10.1007/s00401-026-03027-0
Vancouver
Wu L, Akingbade T, Nelson PT, Wang SJ, Xu B. Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE). Acta Neuropathologica. 2026;151(1). doi:10.1007/s00401-026-03027-0
BibTeX
@article{Wu2026,
author = {Wu, Ling and Akingbade, Tobilola and Nelson, Peter T and Wang, Shih-Hsiu J and Xu, Bin},
title = {Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE)},
journal = {Acta Neuropathologica},
year = {2026},
volume = {151},
number = {1},
doi = {10.1007/s00401-026-03027-0}
}
EUVIMED